The Company is a Korea-based company mainly engaged in the manufacturing of radiolabeled compounds. The Company mainly produces radiolabeled compounds used for in vivo absorption, distribution, metabolism and excretion (ADME) studies. In addition, the Company is also engaged in the Phase I mass balance and micro dosing research. The Company was founded on June 9, 2009 and its shares are listed on Korea Stock Exchaneg on May 18, 2023.

Headquarters
207, Osongsaengmyeong 1-Ro, Osong-Eup, Heungdeok-Gu
Cheongju; Chungcheongbuk;

Contact Details: Purchase the Curachem Co. Ltd. report to view the information.

Website: http://www.curachem.com

Basic Information

Total Employees:

Purchase the Curachem Co. Ltd. report to view the information.

Outstanding Shares:

Purchase the Curachem Co. Ltd. report to view the information.

Financial Auditors:

Purchase the Curachem Co. Ltd. report to view the information.

Incorporation Date:

March 19, 2026

Company Performance

Financial values in the chart are available after Curachem Co. Ltd. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

-22.19%▼

Total Operating Revenue

-22.25%▼

Operating Profit

N/A

EBITDA

-96.4%▼

Net Profit/Loss for the Period

N/A

Total Assets

5.84%▲

Total Equity

-17.2%▼

Operating Profit Margin

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Debt / Equity

39.07%▲

Quick Ratio

-3.66%▼

Cash Ratio

-1.95%▼

Curachem Co. Ltd. (South Korea)